This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

Updated from 2:11 p.m. EDT

Layne Christensen (LAYN - Get Report) shares were leaping Tuesday after the construction company more than doubled its fiscal fourth-quarter income year over year to $6.7 million, or 42 cents a share, on revenue that climbed 31.6% from last year to $193.1 million. Analysts polled by Thomson Financial were seeking 21 cents a share on $158.9 million in sales. Shares of the Kansas-based firm were up $2.81, or 7.6%, to $39.80.

Cell Genesys (CEGE) shares jumped after a midphase trial showed its Gvax prostate-cancer immunotherapy to induce a median survival rate of 35 months in about a quarter of the test population -- those patients receiving dosage similar to that being used in ongoing late-phase testing. A prior midphase trial's results had indicated 26.2-month median survival rate.

The California-based company noted that the current standard of care -- Taxotere chemotherapy plus prednisone -- yielded only 18.9-month median survival in published results. Shares rose $1.39, or 32.3%, to $5.70.

New Jersey's J&J Snack Foods (JJSF - Get Report), which makes Luigi's Italian Ices and licenses the Minute Maid brand name, gained after it bought Whole Food Sorbet and Fruit-A-Freeze Frozen Fruit Bar brands and related assets from CoolBrands International. Terms weren't disclosed. Shares were up 63 cents, or 1.6%, to $40.11.

Iridex (IRIX - Get Report), on the other hand, was plummeting some 20.9% after the medical-equipment maker swung to a fourth-quarter loss of $3.8 million, or 48 cents a share, compared with a nickel-a-share gain last year. Sales shed 13.3% year over year to $9 million, though this roughly meets two analysts' targets.

The Mountain View, Calif., company also said its current liquidity and capital resources are likely insufficient for planned operations over the coming year. The company's auditors have accordingly expressed "substantial doubt as to [Iridex's] ability to continue as a going concern" in its year-end filing. Shares were off $1.85 to $7.01.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CAAS $4.14 0.00%
IRIX $12.12 0.00%
LAYN $8.79 0.00%
JJSF $104.60 0.00%
AAPL $93.24 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs